Skip to content

    HERON THERAPEUTICS, INC. /DE/ (HRTX) stock price & financials

    View HRTX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance75.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $32.81M
    $40.78M
    $38.90M
    $37.20M
    $38.21M
    +16.5%
    $40.59M
    -0.5%
    $34.71M
    -10.8%
    $37.67M
    +1.3%
    Weakening
    Operating Profit
    -$4.46M
    $4.17M
    $3.15M
    -$1.64M
    -$4.09M
    +8.2%
    $38.0K
    -99.1%
    -$4.76M
    -251.1%
    -$2.04M
    -24.9%
    Weakening
    Net Profit
    -$4.85M
    $3.66M
    $2.63M
    -$2.38M
    -$17.50M
    -260.9%
    -$2.95M
    -180.6%
    -$8.11M
    -407.8%
    -$5.49M
    -130.5%
    Weakening
    EPS
    $-0.03
    $0.02
    $-0.02
    $-0.10
    -233.3%
    $-0.04
    -300.0%
    $-0.03
    -50.0%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -13.6%
    10.2%
    8.1%
    -4.4%
    -10.7%
    +21.2%
    0.1%
    -99.1%
    -13.7%
    -269.3%
    -5.4%
    -23.4%
    Weakening
    Tax
    ReturnsROIC
    0.2%
    -0.2%
    -0.1%
    0.1%
    0.9%
    +260.9%
    0.2%
    0.4%
    0.3%
    +130.5%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$31.84M$71.90M$105.14M$90.54M$15.36M$28.68M$25.80M$28.65M$20.72M
    Short-Term Investments
    Total Current Assets$447.25M$479.06M$314.20M$254.42M$205.44M$188.77M$209.01M$238.07M$229.84M
    Net PP&E$14.68M$33.37M$39.01M$33.56M$29.80M$25.60M$17.65M$12.40M$17.41M
    Goodwill
    Intangibles
    Total Assets$462.18M$512.78M$353.56M$305.71M$250.95M$222.51M$233.15M$255.88M$252.26M
    LiabilitiesTotal Current Liabilities$92.02M$96.70M$102.50M$71.06M$82.36M$79.69M$91.46M$96.10M$92.14M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$12.24M$14.56M$8.00M$5.50M$2.80M$0$5.50M
    Total Liabilities$92.02M$108.95M$117.06M$228.14M$237.38M$256.48M$266.80M$241.54M$245.35M
    EquityCommon Stock & APIC$782.0K$903.0K$913.0K$1.02M$1.19M$1.50M$1.52M$1.88M$1.90M
    Retained Earnings-$960.72M-$1.17B-$1.39B-$1.61B-$1.80B-$1.91B-$1.92B-$1.94B-$1.95B
    Total Equity$370.16M$403.83M$236.49M$77.57M$13.57M-$33.97M-$33.65M$14.33M$6.91M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$191.81M-$124.58M-$184.82M-$203.35M-$146.91M-$58.79M-$22.53M-$27.59M-$11.61M
    Cash from Investing-$278.55M-$21.78M$208.96M$32.73M-$3.32M$18.00M$18.71M$16.01M$2.20M
    Cash from Financing$357.61M$186.43M$9.11M$156.03M$75.06M$54.11M$940.0K$14.43M$13.61M
    SummaryCapital Expenditure-$9.17M-$7.15M-$6.81M-$3.02M-$1.82M-$1.54M-$1.71M-$317.0K-$529.0K
    Free Cash Flow-$200.98M-$131.73M-$191.63M-$206.38M-$148.74M-$60.33M-$24.23M-$27.91M-$12.13M
    FCF Margin-259.4%-90.2%-216.2%-239.0%-138.1%-47.5%-16.8%-18.0%-8.0%

    Ratios